Elevation of H3K27me3 level contributes to the radioresistance of nasopharyngeal carcinoma by inhibiting OAS1 expression

Radiotherapy has long been a main treatment option for nasopharyngeal carcinoma (NPC). However, during clinical treatment, NPC is prone to developing radioresistance, resulting in treatment failure. This study aims to examine the role of histone methylation in the induction of radioresistance. It was found that the radioresistance of NPC cells was related to the increase of the level of H3K27me3. Treatment of cells with Histone Methyltransferase Inhibitor GSK126 increased the radiosensitivity of NPC cells by triggering Bcl2/Bax signaling pathway. Bioinformatics analysis indicated that the expression of OAS1 was reduced in the radioresistant cells but increased in the GSK126-treated cells. Chromatin immunoprecipitation assay confirmed that the decrease of OAS1 expression in radioresistant cells was mainly due to the enrichment of H3K27me3 in its promoter region. Furthermore, downregulation of OAS1 reduced Apoptosis due to the inhibition of Bcl2/Bax pathway after irradiation, while OAS1 overexpression increased radiosensitivity. Our findings revealed for the first time that the increase of H3K27me3 level was associated with the decrease of OAS1 expression, leading to the inhibition of Apoptosis and ultimately contributing to the radioresistance of NPC cells. Moreover, the Histone Methyltransferase Inhibitor GSK126 could overcome the radioresistance and thus might be a potential therapeutic strategy for NPC.

GSK126; H3K27me3; Nasopharyngeal carcinoma; OAS1; Radioresistance.